Shanthini Kasturi1,2, Jackie Szymonifka3,4, Jayme C Burket3,4, Jessica R Berman3,4, Kyriakos A Kirou3,4, Alana B Levine3,4, Lisa R Sammaritano3,4, Lisa A Mandl3,4. 1. From the Division of Rheumatology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine, New York, New York, USA. skasturi@tuftsmedicalcenter.org. 2. S. Kasturi, MD, MS, Division of Rheumatology, Department of Medicine, Tufts Medical Center; J. Szymonifka, MA, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery; J.C. Burket, PhD, Healthcare Research Institute, Hospital for Special Surgery; J.R. Berman MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; K.A. Kirou, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; A.B. Levine, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; L.R. Sammaritano, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; and L.A. Mandl, MD, MPH, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine. skasturi@tuftsmedicalcenter.org. 3. From the Division of Rheumatology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine, New York, New York, USA. 4. S. Kasturi, MD, MS, Division of Rheumatology, Department of Medicine, Tufts Medical Center; J. Szymonifka, MA, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery; J.C. Burket, PhD, Healthcare Research Institute, Hospital for Special Surgery; J.R. Berman MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; K.A. Kirou, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; A.B. Levine, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; L.R. Sammaritano, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine; and L.A. Mandl, MD, MPH, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, and Weill Cornell Medicine.
Abstract
OBJECTIVE: To assess the feasibility, validity, and reliability of the Patient Reported Outcomes Measurement Information System Global Health Short Form (PROMIS10) in outpatients with systemic lupus erythematosus (SLE). METHODS: SLE outpatients completed PROMIS10, Medical Outcomes Study Short Form-36 (SF-36), LupusQoL-US, and selected PROMIS computerized adaptive tests (CAT) at routine visits at an SLE Center of Excellence. Construct validity was evaluated by correlating PROMIS10 physical and mental health scores with PROMIS CAT, legacy instruments, and physician-derived measures of disease activity and damage. Test-retest reliability was determined among subjects reporting stable SLE activity at 2 assessments 1 week apart using intraclass correlation coefficients (ICC). RESULTS: A diverse cohort of 204 out of 238 patients with SLE (86%) completed survey instruments. PROMIS10 physical health scores strongly correlated with physical function, pain, and social health domains in PROMIS CAT, SF-36, and LupusQoL, while mental health scores strongly correlated with PROMIS depression CAT, SF-36, and LupusQoL mental health domains (Spearman correlations ≥ 0.70). Active arthritis, comorbid fibromyalgia (FM), and anxiety were associated with worse PROMIS10 scores, but sociodemographic factors and physician-assessed flare status were not. Test-retest reliability for PROMIS10 physical and mental health scores was high (ICC ≥ 0.85). PROMIS10 required < 2 minutes to complete. CONCLUSION: PROMIS10 is valid and reliable, and can efficiently screen for impaired physical function, pain, and emotional distress in outpatients with SLE. With strong correlations to LupusQoL and SF-36 but significantly reduced responder burden, PROMIS10 is a promising tool for measuring patient-reported outcomes in routine SLE clinical care and value-based healthcare initiatives.
OBJECTIVE: To assess the feasibility, validity, and reliability of the Patient Reported Outcomes Measurement Information System Global Health Short Form (PROMIS10) in outpatients with systemic lupus erythematosus (SLE). METHODS:SLE outpatients completed PROMIS10, Medical Outcomes Study Short Form-36 (SF-36), LupusQoL-US, and selected PROMIS computerized adaptive tests (CAT) at routine visits at an SLE Center of Excellence. Construct validity was evaluated by correlating PROMIS10 physical and mental health scores with PROMIS CAT, legacy instruments, and physician-derived measures of disease activity and damage. Test-retest reliability was determined among subjects reporting stable SLE activity at 2 assessments 1 week apart using intraclass correlation coefficients (ICC). RESULTS: A diverse cohort of 204 out of 238 patients with SLE (86%) completed survey instruments. PROMIS10 physical health scores strongly correlated with physical function, pain, and social health domains in PROMIS CAT, SF-36, and LupusQoL, while mental health scores strongly correlated with PROMIS depression CAT, SF-36, and LupusQoL mental health domains (Spearman correlations ≥ 0.70). Active arthritis, comorbid fibromyalgia (FM), and anxiety were associated with worse PROMIS10 scores, but sociodemographic factors and physician-assessed flare status were not. Test-retest reliability for PROMIS10 physical and mental health scores was high (ICC ≥ 0.85). PROMIS10 required < 2 minutes to complete. CONCLUSION: PROMIS10 is valid and reliable, and can efficiently screen for impaired physical function, pain, and emotional distress in outpatients with SLE. With strong correlations to LupusQoL and SF-36 but significantly reduced responder burden, PROMIS10 is a promising tool for measuring patient-reported outcomes in routine SLE clinical care and value-based healthcare initiatives.
Entities:
Keywords:
PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION STUDY
Authors: Lisa G Suter; Claire E Barber; Jeph Herrin; Amye Leong; Elena Losina; Amy Miller; Eric Newman; Mark Robbins; Heather Tory; Jinoos Yazdany Journal: Arthritis Care Res (Hoboken) Date: 2016-09-16 Impact factor: 4.794
Authors: Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon Journal: N Engl J Med Date: 2005-12-15 Impact factor: 91.245
Authors: Shanthini Kasturi; Jackie Szymonifka; Jayme C Burket; Jessica R Berman; Kyriakos A Kirou; Alana B Levine; Lisa R Sammaritano; Lisa A Mandl Journal: J Rheumatol Date: 2017-04-15 Impact factor: 4.666
Authors: D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma Journal: Arthritis Rheum Date: 1996-03
Authors: David T Eton; Timothy J Beebe; Philip T Hagen; Michele Y Halyard; Victor M Montori; James M Naessens; Jeff A Sloan; Carrie A Thompson; Douglas L Wood Journal: Patient Relat Outcome Meas Date: 2014-02-10
Authors: Aditya V Karhade; David N Bernstein; Vineet Desai; Hany S Bedair; Evan A O'Donnell; Miho J Tanaka; Christopher M Bono; Mitchel B Harris; Joseph H Schwab; Daniel G Tobert Journal: Clin Orthop Relat Res Date: 2022-05-10 Impact factor: 4.755
Authors: Patricia Katz; Jinoos Yazdany; Laura Trupin; Stephanie Rush; Charles G Helmick; Louise B Murphy; Cristina Lanata; Lindsey A Criswell; Maria Dall'Era Journal: Arthritis Care Res (Hoboken) Date: 2019-11-05 Impact factor: 4.794
Authors: Brittany R Lapin; Ryan Honomichl; Nicolas Thompson; Susannah Rose; Abby Abelson; Chad Deal; Irene L Katzan Journal: Qual Life Res Date: 2020-11-10 Impact factor: 4.147
Authors: Aziyadé Knippenberg; George A Robinson; Chris Wincup; Coziana Ciurtin; Elizabeth C Jury; Anastasia Z Kalea Journal: Lupus Date: 2022-01-03 Impact factor: 2.858
Authors: Noelle E Carlozzi; Sung Won Choi; Zhenke Wu; Jennifer A Miner; Angela K Lyden; Christopher Graves; Jitao Wang; Srijan Sen Journal: JMIR Res Protoc Date: 2021-12-09
Authors: Sreten Franovic; Caleb M Gulledge; Noah A Kuhlmann; Tyler H Williford; Chaoyang Chen; Eric C Makhni Journal: JB JS Open Access Date: 2019-12-10
Authors: Patricia Katz; Sofia Pedro; Evo Alemao; Jinoos Yazdany; Maria Dall'Era; Laura Trupin; Stephanie Rush; Kaleb Michaud Journal: ACR Open Rheumatol Date: 2019-12-04